Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-21-000076

Chief Financial Officer gave up 1,823 shares (to pay taxes)

  • Chief Financial Officer acquired 5,753 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Biller Jonathan · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-12-03 Exercise or conversion : show line 1 in the form +5,753 16,623 D
2021-12-03 Shares withheld for taxes : show line 2 in the form −1,823 $35.88 $65,406 14,800 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-12-03 Exercise or conversion : show line 3 in the form Restricted stock units −5,753 5,753 D
Loading xslF345X03/wf-form4_163891189929319.xml…